Pashayan Nora, Lyratzopoulos Georgios, Mathur Raj
Department of Public Health and Primary Care, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge CB2 2SR, UK.
BMC Health Serv Res. 2006 Jun 23;6:80. doi: 10.1186/1472-6963-6-80.
In unexplained and mild male factor subfertility, both intrauterine insemination (IUI) and in-vitro fertilisation (IVF) are indicated as first line treatments. Because the success rate of IUI is low, many couples failing IUI subsequently require IVF treatment. In practice, it is therefore important to examine the comparative outcomes (live birth-producing pregnancy), costs, and cost-effectiveness of primary offer of IVF, compared with primary offer of IUI followed by IVF for couples failing IUI.
Mathematical modelling was used to estimate comparative clinical and cost effectiveness of either primary offer of one full IVF cycle (including frozen cycles when applicable) or "IUI + IVF" (defined as primary IUI followed by IVF for IUI failures) to a hypothetical cohort of subfertile couples who are eligible for both treatment strategies. Data used in calculations were derived from the published peer-reviewed literature as well as activity data of local infertility units.
Cost-effectiveness ratios for IVF, "unstimulated-IUI (U-IUI) + IVF", and "stimulated IUI (S-IUI) + IVF" were 12,600 pounds sterling, 13,100 pound sterling and 15,100 pound sterling per live birth-producing pregnancy respectively. For a hypothetical cohort of 100 couples with unexplained or mild male factor subfertility, compared with primary offer of IVF, 6 cycles of "U-IUI + IVF" or of "S-IUI + IVF" would cost an additional 174,200 pounds sterling and 438,000 pounds sterling, representing an opportunity cost of 54 and 136 additional IVF cycles and 14 to 35 live birth-producing pregnancies respectively.
For couples with unexplained and mild male factor subfertility, primary offer of a full IVF cycle is less costly and more cost-effective than providing IUI (of any modality) followed by IVF.
在不明原因的轻度男性因素不育症中,宫腔内人工授精(IUI)和体外受精(IVF)均被列为一线治疗方法。由于IUI的成功率较低,许多接受IUI治疗失败的夫妇随后需要进行IVF治疗。因此,在实际操作中,对于不明原因或轻度男性因素不育且符合两种治疗策略的夫妇,比较首次提供IVF与先提供IUI然后对IUI失败的夫妇进行IVF的相对结果(产生活产的妊娠)、成本和成本效益非常重要。
采用数学模型来估计对一组符合两种治疗策略的不育夫妇首次提供一个完整的IVF周期(适当时包括冷冻周期)或“IUI+IVF”(定义为先进行IUI,然后对IUI失败的夫妇进行IVF)的相对临床效果和成本效益。计算中使用的数据来自已发表的同行评审文献以及当地不孕不育治疗机构的活动数据。
IVF、“非刺激IUI(U-IUI)+IVF”和“刺激IUI(S-IUI)+IVF”每例产生活产的妊娠的成本效益比分别为12,600英镑、13,100英镑和15,100英镑。对于一组假设的100对不明原因或轻度男性因素不育的夫妇,与首次提供IVF相比,6个周期的“U-IUI+IVF”或“S-IUI+IVF”将额外花费174,200英镑和438,000英镑,分别代表54个和136个额外IVF周期的机会成本,以及分别14至35例产生活产的妊娠。
对于不明原因和轻度男性因素不育的夫妇,首次提供一个完整的IVF周期比先提供任何方式的IUI然后进行IVF成本更低且更具成本效益。